Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

A. Moran; B. Bundy; D. J. Becker; L. A. DiMeglio; S. E. Gitelman; R. Goland; C. J. Greenbaum; K. C. Herold; J. B. Marks; P. Raskin; S. Sanda; D. Schatz; D. Wherrett; D. M. Wilson; J. P. Krischer; J. S. Skyler; L. Pickersgill; E. De Koning; A. G. Ziegler; B. Böehm; K. Badenhoop; N. Schloot; J. F. Bak; P. Pozzilli; D. Mauricio; M. Y. Donath; L. Castaño; A. Wägner; H. H. Lervang; H. Perrild; T. Mandrup-Poulsen

doi:10.1089/dia.2014.1510

Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

A. Moran
, B. Bundy
, D. J. Becker
, L. A. DiMeglio
, S. E. Gitelman
, R. Goland
, C. J. Greenbaum
, K. C. Herold
, J. B. Marks
, P. Raskin
, S. Sanda
, D. Schatz
, D. Wherrett
, D. M. Wilson
, J. P. Krischer
, J. S. Skyler
, L. Pickersgill
, E. De Koning
, A. G. Ziegler
, B. Böehm

K. Badenhoop, N. Schloot, J. F. Bak, P. Pozzilli, D. Mauricio, M. Y. Donath, L. Castaño, A. Wägner, H. H. Lervang, H. Perrild, T. Mandrup-Poulsen

Pediatric Endocrinology

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	S87
Journal	Diabetes Technology and Therapeutics
Volume	16
Issue number	SUPPL. 1
DOIs	https://doi.org/10.1089/dia.2014.1510
State	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1089/dia.2014.1510

Find It

Find It at U of M Libraries

Cite this

Moran, A., Bundy, B., Becker, D. J., DiMeglio, L. A., Gitelman, S. E., Goland, R., Greenbaum, C. J., Herold, K. C., Marks, J. B., Raskin, P., Sanda, S., Schatz, D., Wherrett, D., Wilson, D. M., Krischer, J. P., Skyler, J. S., Pickersgill, L., De Koning, E., Ziegler, A. G., ... Mandrup-Poulsen, T. (2014). Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials. Diabetes Technology and Therapeutics, 16(SUPPL. 1), S87. https://doi.org/10.1089/dia.2014.1510

Moran, A, Bundy, B, Becker, DJ, DiMeglio, LA, Gitelman, SE, Goland, R, Greenbaum, CJ, Herold, KC, Marks, JB, Raskin, P, Sanda, S, Schatz, D, Wherrett, D, Wilson, DM, Krischer, JP, Skyler, JS, Pickersgill, L, De Koning, E, Ziegler, AG, Böehm, B, Badenhoop, K, Schloot, N, Bak, JF, Pozzilli, P, Mauricio, D, Donath, MY, Castaño, L, Wägner, A, Lervang, HH, Perrild, H & Mandrup-Poulsen, T 2014, 'Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials', Diabetes Technology and Therapeutics, vol. 16, no. SUPPL. 1, pp. S87. https://doi.org/10.1089/dia.2014.1510

@article{b8d60175f7c0465a871249d75699d0b8,

title = "Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials",

author = "A. Moran and B. Bundy and Becker, \{D. J.\} and DiMeglio, \{L. A.\} and Gitelman, \{S. E.\} and R. Goland and Greenbaum, \{C. J.\} and Herold, \{K. C.\} and Marks, \{J. B.\} and P. Raskin and S. Sanda and D. Schatz and D. Wherrett and Wilson, \{D. M.\} and Krischer, \{J. P.\} and Skyler, \{J. S.\} and L. Pickersgill and \{De Koning\}, E. and Ziegler, \{A. G.\} and B. B{\"o}ehm and K. Badenhoop and N. Schloot and Bak, \{J. F.\} and P. Pozzilli and D. Mauricio and Donath, \{M. Y.\} and L. Casta{\~n}o and A. W{\"a}gner and Lervang, \{H. H.\} and H. Perrild and T. Mandrup-Poulsen",

year = "2014",

doi = "10.1089/dia.2014.1510",

language = "English (US)",

volume = "16",

pages = "S87",

journal = "Diabetes Technology and Therapeutics",

issn = "1520-9156",

publisher = "Mary Ann Liebert Inc.",

number = "SUPPL. 1",

}

TY - JOUR

T1 - Interleukin-1 antagonism in type 1 diabetes of recent onset

T2 - Two multicenter, randomized double-masked, placebo-controlled trials

AU - Moran, A.

AU - Bundy, B.

AU - Becker, D. J.

AU - DiMeglio, L. A.

AU - Gitelman, S. E.

AU - Goland, R.

AU - Greenbaum, C. J.

AU - Herold, K. C.

AU - Marks, J. B.

AU - Raskin, P.

AU - Sanda, S.

AU - Schatz, D.

AU - Wherrett, D.

AU - Wilson, D. M.

AU - Krischer, J. P.

AU - Skyler, J. S.

AU - Pickersgill, L.

AU - De Koning, E.

AU - Ziegler, A. G.

AU - Böehm, B.

AU - Badenhoop, K.

AU - Schloot, N.

AU - Bak, J. F.

AU - Pozzilli, P.

AU - Mauricio, D.

AU - Donath, M. Y.

AU - Castaño, L.

AU - Wägner, A.

AU - Lervang, H. H.

AU - Perrild, H.

AU - Mandrup-Poulsen, T.

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84893300757

UR - https://www.scopus.com/pages/publications/84893300757#tab=citedBy

U2 - 10.1089/dia.2014.1510

DO - 10.1089/dia.2014.1510

M3 - Comment/debate

AN - SCOPUS:84893300757

SN - 1520-9156

VL - 16

SP - S87

JO - Diabetes Technology and Therapeutics

JF - Diabetes Technology and Therapeutics

IS - SUPPL. 1

ER -

Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials

UN SDGs

Publisher link

Find It

Other files and links

Cite this